| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/30/2011 | EP2301585A1 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 03/30/2011 | EP2301584A1 Methods and compositions for treatment of interferon-resistant tumors |
| 03/30/2011 | EP2301580A1 Anti-VEGF antibodies |
| 03/30/2011 | EP2301578A2 Methods for treating TWEAK-related conditions |
| 03/30/2011 | EP2301577A2 Methods for treating TWEAK-related conditions |
| 03/30/2011 | EP2301569A2 Vaccine and method for treatment of neurodegenerative diseases |
| 03/30/2011 | EP2301567A1 Selective immune down regulation (SIDR) for transplantation |
| 03/30/2011 | EP2301566A1 DNA vaccines encoding heat shock proteins |
| 03/30/2011 | EP2301565A1 Use of proteasome inhibitors for the treatment of viral infections |
| 03/30/2011 | EP2301564A1 Compositions and methods for promoting neuronal outgrowth |
| 03/30/2011 | EP2301563A2 HSP20 peptides |
| 03/30/2011 | EP2301562A1 Irrigation solution and method for inhibition of pain, inflammation and spasm |
| 03/30/2011 | EP2301561A1 Pharmaceutical composition for treatment of dry eye and/or corneal/conjunctival disorders |
| 03/30/2011 | EP2301560A1 Pharmaceutical agent for promoting the functional regeneration of damaged tissue |
| 03/30/2011 | EP2301559A1 Agent for recruitment of bone-marrow-derived pluripotent stem cell into peripheral circulation |
| 03/30/2011 | EP2301553A1 Polynucleotide therapy |
| 03/30/2011 | EP2301552A1 Polynucleotide therapy |
| 03/30/2011 | EP2301531A2 Combinations and modes of administration of therapeutic agents and combination therapy |
| 03/30/2011 | EP2300624A1 Biomarkers for painful intervertebral discs and methods of use thereof |
| 03/30/2011 | EP2300607A2 Method for treating and preventing radiation damage using genetically modified mesenchymal stem cells |
| 03/30/2011 | EP2300604A1 Nitric oxide compositions and devices and methods for cosmesis |
| 03/30/2011 | EP2300603A1 Nitric oxide device and method for wound healing, treatment of dermatological disorders and microbial infections |
| 03/30/2011 | EP2300496A1 Methods of treating atherosclerosis |
| 03/30/2011 | EP2300495A1 Solutions for tissue engineering and methods of use |
| 03/30/2011 | EP2300494A1 Anti-amyloid immunogenic compositions, methods and uses |
| 03/30/2011 | EP2300492A1 A novel antiviral peptide against avian influenza virus h9n2 |
| 03/30/2011 | EP2300491A1 Hepatitis c virus inhibitors |
| 03/30/2011 | EP2300049A1 Use of a dead-box rna helicase for inducing cytokine production |
| 03/30/2011 | EP2300048A1 Lipocalin-2 as a prognostic and diagnostic marker for heart and stroke risks |
| 03/30/2011 | EP2300047A1 Heat-stable, aqueous lactoferrin composition and its preparation and use |
| 03/30/2011 | EP2300046A2 Super fast-acting insulin compositions |
| 03/30/2011 | EP2300045A1 Treatment of metastatic tumors |
| 03/30/2011 | EP2300044A1 Methods and compositions for the management of pain using omega-conotoxins |
| 03/30/2011 | EP2300043A1 Analgesic effects of peptide toxin apetx2 |
| 03/30/2011 | EP2300042A2 Compositions and methods to treat urinary incontinence |
| 03/30/2011 | EP2300041A2 Compositions and methods for treating or preventing prostate cancer and for detecting androgen receptor variants |
| 03/30/2011 | EP2300040A2 Methods and compositions for prostate cancer immunotherapy |
| 03/30/2011 | EP2300039A2 ANXIOLYTIC COMPOSITION CONTAINING ALPHAs¹-CASEIN -DERIVED PEPTIDES |
| 03/30/2011 | EP2300038A2 Improved peptide mediators of cholesterol efflux |
| 03/30/2011 | EP2300037A2 Glucagon/glp-1 receptor co-agonists |
| 03/30/2011 | EP2300036A1 Melanocortin receptor-specific peptides for treatment of sexual dysfunction |
| 03/30/2011 | EP2300035A2 Gip-based mixed agonists for treatment of metabolic disorders and obesity |
| 03/30/2011 | EP2300034A2 Xbp1, cd138, and cs1 peptides |
| 03/30/2011 | EP2300033A1 Collagen peptide conjugates and uses therefor |
| 03/30/2011 | EP2300032A2 Metal abstraction peptide (map) tag and associated methods |
| 03/30/2011 | EP2300031A2 Methods and compositions for oral administration of exenatide |
| 03/30/2011 | EP2300023A2 Microorganisms for preventing and treating neoplasms accompanying cellular therapy |
| 03/30/2011 | EP2299995A1 Combination of amidine derivates with cyclic depsipeptides |
| 03/30/2011 | EP2299975A1 Preparation and iontophorectic device for the transdermal application of active ingredients |
| 03/30/2011 | EP2185588B1 Synthetic pulmonary surfactant peptides |
| 03/30/2011 | EP2121736B1 New anti-malaria vaccine compositions and uses thereof |
| 03/30/2011 | EP1948216B1 Treatment of acute renal failure with soluble thrombomodulin |
| 03/30/2011 | EP1843789B1 Compositions and methods for treating fibrotic disorders |
| 03/30/2011 | EP1641488B1 Epitope composition for enteric administration prepared by hydrolysis of antigenic structures with chymotrypsin |
| 03/30/2011 | EP1517710B1 Pegylated factor vii glycoforms |
| 03/30/2011 | EP1506172B1 Hepatitis c virus inhibitors |
| 03/30/2011 | EP1409006B1 Monodispersed mixtures and methods of treating diabetes |
| 03/30/2011 | EP1394261B1 Antigens for immunisation |
| 03/30/2011 | EP1355658B1 Anti HER3 antibody for diagnosis, prevention and treatment of hyperproliferative diseases |
| 03/30/2011 | EP1337242B1 Gene delivery formulations for treatment of ischemic conditions |
| 03/30/2011 | EP1317485B1 Myostatin antagonists and uses thereof |
| 03/30/2011 | EP1196196B8 Conjugate for mediating cell, compartment or membrane-specific transport of active substances |
| 03/30/2011 | EP1053023B2 Systemic delivery of serum stable plasmid lipid particles for cancer therapy |
| 03/30/2011 | CN1950101B Use of peptidic compounds for the prophylaxis and treatment of chronic headache |
| 03/30/2011 | CN1906208B Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases |
| 03/30/2011 | CN1849133B Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke |
| 03/30/2011 | CN101998989A Identification of TRPML3 (MCOLN3) as a salty taste receptor and use in assays for identifying taste (salty) modulators and/or therapeutics that modulate sodium transport, absorption or excretion and/or aldosterone and/or vasopressin production or release |
| 03/30/2011 | CN101998965A Immunosuppressive polypeptides and nucleic acid |
| 03/30/2011 | CN101998864A 调节t细胞依赖性免疫应答的方法 The method of regulating cell-dependent immune response t |
| 03/30/2011 | CN101998862A Collagen products and methods for producing collagen products |
| 03/30/2011 | CN101998861A Method of treating prostate cancer with the gnrh antagonist degarelix |
| 03/30/2011 | CN101998860A Compositions and methods for delivery of glycopeptide antibiotics to medical device surfaces |
| 03/30/2011 | CN101993497A Human proliferation-inducing ligand blocking agent and preparation method and application thereof |
| 03/30/2011 | CN101993496A Dual blood sugar and blood fat adjusting fusion protein and preparation method and application thereof |
| 03/30/2011 | CN101993494A N-terminal chemical modification and application of human fibroblast growth factor-21 (hFGF-21) |
| 03/30/2011 | CN101993489A Reversible hirudin |
| 03/30/2011 | CN101993485A Peptide analog homologous dimer capable of accelerating insulin secretion and application thereof |
| 03/30/2011 | CN101991842A Method for establishing chronic obstructive pulmonary disease superposition asthma model |
| 03/30/2011 | CN101991841A Medical composition for treating cancer and preparation method thereof |
| 03/30/2011 | CN101991840A Method for preparing prostate cancer-resisting mussel enzymolytic extract and application thereof |
| 03/30/2011 | CN101991613A Diarrhea and dysentery arresting medicine and preparation method thereof |
| 03/30/2011 | CN101991557A Liquid vancomycin hydrochloride capsule and preparation method thereof |
| 03/30/2011 | CN101991548A Reduced glutathione freeze-dried powder injection and preparation method thereof |
| 03/30/2011 | CN101385852B Preparation method of bone collagen tablet |
| 03/30/2011 | CN101244259B Thymus gland peptide alpha1sustained-release microsphere preparation for injection and preparation thereof |
| 03/30/2011 | CN101199836B Stage releasing CsA solid tiny milk agent and tiny milk curing method thereof |
| 03/30/2011 | CN101045163B High molecular anticarcinogenic prodrug, its preparing method and use |
| 03/30/2011 | CN101043899B Refolding transforming growth factor beta family proteins |
| 03/29/2011 | US7915400 RNA interference mediated inhibition of hepatitis C virus (HCV) gene expression using short interfering nucleic acid (siNA) |
| 03/29/2011 | US7915395 Plasmid coding immunogenic fusion protein for use as drug delivery tool; antiproliferative agents; genetic vaccines |
| 03/29/2011 | US7915393 Compositions and methods for WT1 specific immunotherapy |
| 03/29/2011 | US7915386 Method of producing an interferon-β complex |
| 03/29/2011 | US7915382 Antifungal bifunctional molecules, methods of construction and methods of treating fungal infection therewith |
| 03/29/2011 | US7915380 Compositions, systems and methods for the diagnosis, prevention and treatment of disorders associated with azetidine-2-carboxylic acid |
| 03/29/2011 | US7915291 Hepatitis C virus inhibitors |
| 03/29/2011 | US7915231 Antisense modulation of C-reactive protein expression |
| 03/29/2011 | US7915230 Reagents for transfection of eukaryotic cells |
| 03/29/2011 | US7915226 Methods of suppressing microglial activation |
| 03/29/2011 | US7915225 Soluble tumor necrosis factor receptor treatment of medical disorders |
| 03/29/2011 | US7915224 Method of preparing peptide |